Total Funding
29
49
Total FundingSeed raised
Growth Score
-2 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
221091
Biotechnology company developing contrast media and nanotherapeutics for cancer diagnosis and treatment.
- Sruthy Surendran: Co-Founder and Finance Manager
- Nandu Surendran: Co-Founder and Managing Director
About the Company
B-Aegis is a customer-centric biotechnology company formed in 2017 for solving the most complex problems in healthcare sectors. Team B-Aegis is translating scientific breakthroughs into real-life products by combining nanotechnology, medicinal chemistry, life sciences and material sciences. The team focuses on developing solutions for chronic
illnesses like cancer and emerging threats like antimicrobial-resistant infections.
